Cargando…
Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson’s Disease: A Potential Disease Biomarker
Parkinson’s disease (PD) is the second most common neurodegenerative disease, which still lacks a biomarker to aid in diagnosis and to differentiate diagnosis at the early stage of the disease. microRNAs (miRNAs) are small and evolutionary conserved non-coding RNAs that are involved in post-transcri...
Autores principales: | Yang, Zhaofei, Li, Tianbai, Cui, Yanhua, Li, Song, Cheng, Cheng, Shen, Bairong, Le, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431626/ https://www.ncbi.nlm.nih.gov/pubmed/30936821 http://dx.doi.org/10.3389/fnins.2019.00218 |
Ejemplares similares
-
Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018) -
Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson’s disease
por: Li, Tianbai, et al.
Publicado: (2020) -
Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis
por: Cui, Yanhua, et al.
Publicado: (2022) -
Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022) -
Abnormal Vacuole Membrane Protein-1 Expression in Parkinson’s Disease Patients
por: Al-Nusaif, Murad, et al.
Publicado: (2022)